Record NNP B-NP O
date NN I-NP O
: : O O
2149-03-18 CD O B-DATE
CARDIOLOGY NN B-NP O
BETHANY NNP B-NP B-HOSPITAL
BRETHREN NNP I-NP I-HOSPITAL
HOSPITAL NNP I-NP I-HOSPITAL
Reason NN B-NP O
for IN B-PP O
visit NN B-NP O
: : O O
Mr. NNP B-NP O
Eubanks NNS I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
68 CD I-NP B-AGE
yo NNP I-NP O
man NN I-NP O
w/ VBD B-VP O
recently RB I-VP O
diagnosed VBN I-VP O
CAD NN B-NP O
s/p NN I-NP O
LAD NN I-NP O
stent NN I-NP O
. . O O
Interval NNP B-NP O
History NN I-NP O
: : O O
Mr NNP B-NP O
Eubanks NNS I-NP B-PATIENT
presents VBZ B-VP O
for IN B-PP O
hospital NN B-NP O
followup NN I-NP O
after IN B-PP O
presenting VBG B-VP O
to TO B-PP O
BBH NNP B-NP B-HOSPITAL
in IN B-PP O
January NNP B-NP B-DATE
2149 CD I-NP I-DATE
w/ , O O
after IN B-SBAR O
he PRP B-NP O
developed VBD B-VP O
2 CD B-NP O
episodes NNS I-NP O
of IN B-PP O
chest NN B-NP O
pain NN I-NP O
lasting VBG B-VP O
1-2 JJ B-NP O
minutes NNS I-NP O
each DT B-NP O
and CC I-NP O
not RB I-NP O
associated VBN B-VP O
with IN B-PP O
any DT B-NP O
symptoms NNS I-NP O
. . O O
On IN B-PP O
the DT B-NP O
morning NN I-NP O
of IN B-PP O
admission NN B-NP O
, , O O
patient NN B-NP O
developed VBN B-VP O
more RBR B-NP O
severe JJ I-NP O
chest NN I-NP O
pain NN I-NP O
and CC I-NP O
pressure NN I-NP O
radiating NN I-NP O
to TO B-PP O
both DT B-NP O
arms NNS I-NP O
and CC I-NP O
back RB I-NP O
. . O O
Pain NNP B-NP O
persisted VBD B-VP O
for IN B-PP O
2 CD B-NP O
hours NNS I-NP O
, , O O
prompting VBG B-VP O
the DT B-NP O
patient NN I-NP O
to TO B-VP O
present VB I-VP O
to TO B-PP O
the DT B-NP O
BBH NNP I-NP B-HOSPITAL
ED NNP I-NP O
for IN B-PP O
further JJ B-NP O
care NN I-NP O
. . O O
In IN B-PP O
the DT B-NP O
ED NNP I-NP O
, , O O
patient NN B-NP O
was VBD B-VP O
treated VBN I-VP O
with IN B-PP O
ASA NNP B-NP O
, , O O
metoprolol NN B-NP O
, , O O
sl JJ B-NP O
NTG NNP I-NP O
, , O O
and CC O O
chest NN B-NP O
pain NN I-NP O
resolved VBN B-VP O
. . B-NP O
EKGs NNP I-NP O
showed VBD B-VP O
biphasic JJ B-NP O
T-waves NNS I-NP O
in IN B-PP O
V4-5 DT B-NP O
. . O O
CT NNP B-NP O
scan NN I-NP O
was VBD B-VP O
negative JJ B-ADJP O
for IN B-PP O
aortic JJ B-NP O
dissection NN I-NP O
or CC O O
other JJ B-NP O
acute JJ I-NP O
pathology NN I-NP O
. . O O
Cardiac NNP B-NP O
markers NNS I-NP O
were VBD B-VP O
negative JJ B-ADJP O
. . O O
Patient NNP B-NP O
was VBD B-VP O
admitted VBN I-VP O
to TO B-PP O
the DT B-NP O
Internal NNP I-NP O
Medicine NNP I-NP O
service NN I-NP O
for IN B-PP O
further JJ B-NP O
management NN I-NP O
. . O O
Of IN B-PP O
note NN B-NP O
, , O O
at IN B-PP O
Pennsylvania NNP B-NP B-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
, , O O
patient NN B-NP O
had VBD B-VP O
a DT B-NP O
positive JJ I-NP O
ETTMIBI NNP I-NP O
showing VBG B-VP O
fixed VBN I-VP O
+ RB B-NP O
mild JJ I-NP O
reversible JJ I-NP O
defect NN I-NP O
in IN B-PP O
the DT B-NP O
inferoapical JJ I-NP O
region NN I-NP O
in IN B-PP O
2/47 CD B-NP B-DATE
, , O O
followed VBD B-VP O
up RP B-PRT O
with IN B-NP O
normal JJ I-NP O
exercise NN I-NP O
echo NN I-NP O
in IN B-PP O
5/47 CD B-NP B-DATE
. . O O
On IN B-PP O
first JJ B-NP O
night NN I-NP O
of IN B-PP O
admission NN B-NP O
, , O O
patient NN B-NP O
developed VBD B-VP O
recurrent JJ B-NP O
chest NN I-NP O
pain NN I-NP O
when WRB B-VP O
going VBG I-VP O
to TO B-PP O
the DT B-NP O
bathroom NN I-NP O
. . O O
Because IN B-PP O
of IN I-PP O
his PRP$ B-NP O
risk NN I-NP O
factors NNS I-NP O
for IN B-PP O
disease NN B-NP O
, , O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN I-VP O
to TO I-VP O
proceed VB I-VP O
directly RB B-ADVP O
to TO B-PP O
cardiac NN B-NP O
catheterization NN I-NP O
. . O O
In IN B-PP O
the DT B-NP O
cath NN I-NP O
lab NN I-NP O
, , O O
patient NN B-NP O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
multivessel NN B-NP O
CAD NN I-NP O
with IN B-PP O
an DT B-NP O
LAD NN I-NP O
culprit NN I-NP O
. . O O
He PRP B-NP O
received VBD B-VP O
3xCypher JJ B-NP O
stents NNS I-NP O
to TO B-PP O
the DT B-NP O
mid JJ I-NP O
and CC I-NP O
distal JJ I-NP O
LAD NN I-NP O
with IN B-PP O
residual JJ B-NP O
flow NN I-NP O
limitation NN I-NP O
. . B-NP O
RCA NN I-NP O
with IN B-PP O
moderate JJ B-NP O
disease NN I-NP O
. . O O
LCx '' O O
with IN B-PP O
distal JJ B-NP O
disease NN I-NP O
. . O O
Patient NNP B-NP O
was VBD B-VP O
transferred VBN I-VP O
to TO B-PP O
the DT B-NP O
SDU NNP I-NP O
for IN B-PP O
further JJ B-NP O
care NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
started VBN I-VP O
on IN B-PP O
beta-blockers NNS B-NP O
and CC I-NP O
ace-inhibition NN I-NP O
, , O O
and CC O O
tolerated VBD B-VP O
these DT B-NP O
medications NNS I-NP O
well RB B-ADVP O
. . O O
He PRP B-NP O
was VBD B-VP O
evaluated VBN I-VP O
for IN B-PP O
cardiac JJ B-NP O
rehab NN I-NP O
. . O O
Of IN B-PP O
note NN B-NP O
, , O O
patient NN B-NP O
was VBD B-VP O
informed VBN I-VP O
of IN B-PP O
the DT B-NP O
pulmonary JJ I-NP O
nodule NN I-NP O
located VBN B-VP O
on IN B-PP O
CT NNP B-NP O
scan NN I-NP O
and CC O O
the DT B-NP O
need NN I-NP O
for IN B-PP O
follow-up JJ B-NP O
CT NNP I-NP O
in IN B-PP O
3 CD B-NP O
months NNS I-NP O
. . O O
Past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
: : O O
CAD NN B-NP O
as RB I-NP O
above IN O O
HTN . O O
Hyperlipidemia NNP B-NP O
Gout CC O O
DM NNP B-NP O
type NN I-NP O
2 CD O O
GERD NNP B-NP O
Pulmonary NNP B-NP O
nodule NN I-NP O
Medications NNS B-NP O
( -LRB- B-VP O
Confirmed VBN B-NP O
) -RRB- I-NP O
: : O O
ASA NNP B-NP O
325 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd . O O
atenolol NN B-NP O
Indocin IN B-PP O
50 CD B-NP O
mg JJ I-NP O
po NN I-NP O
bid NN I-NP O
PRN NNP I-NP O
gout NN I-NP O
flares NNS I-NP O
Lipitor NNP B-NP O
80mg CD I-NP O
po NN I-NP O
qd NN I-NP O
lisinopril NN B-NP O
omeprazole NN B-NP O
Plavix NN B-NP O
Allergies NNP B-NP O
: : O O
Drug NN B-NP O
allergy NN I-NP O
Allopurinol NNP I-NP O
led VBD B-VP O
to TO B-PP O
hives NNS B-NP O
. . O O
Family NNP B-NP O
history NN I-NP O
: : O O
Mother NN B-NP O
died VBD B-VP O
at IN B-PP O
89 CD B-NP B-AGE
, , O O
had VBD B-VP O
heart NN B-NP O
disease NN I-NP O
. . O O
Father NN B-NP O
died VBD B-VP O
young JJ B-ADJP O
of IN B-PP O
a DT B-NP O
brain NN I-NP O
tumor NN I-NP O
, , O O
Brother NNP B-NP O
with IN B-PP O
CAD NNP B-NP O
in IN B-PP O
40s CD B-NP B-AGE
,Sister NN I-NP O
with IN B-PP O
CAD NN B-NP O
Social JJ B-NP O
history NN I-NP O
: : O O
Lives NNS B-NP O
in IN B-PP O
Cheney NNP B-NP B-CITY
with IN B-PP O
wife NN B-NP O
. . O O
economic JJ B-NP B-PROFESSION
assessor NN I-NP I-PROFESSION
. . B-NP O
Tobacco NN I-NP O
- : O O
none NN B-NP O
, , O O
Alcohol NNP B-NP O
- : O O
occasional JJ B-NP O
, , O O
Drugs NNS B-NP O
- : O O
none NN B-NP O
Review NNP B-NP O
of IN B-PP O
systems NNS B-NP O
: : O O
Otherwise RB B-ADVP O
negative JJ B-ADJP O
in IN B-PP O
detail NN B-NP O
Physical JJ B-NP O
examination NN I-NP O
: : O O
-BMI JJ B-NP O
: : O O
24.2 CD B-NP O
Normal JJ I-NP O
, , I-NP O
low JJ I-NP O
risk NN I-NP O
-Pulse JJ B-NP O
: : O O
68 CD O O
-resp. DT B-NP O
rate NN I-NP O
: : O O
18 CD O O
-height NN B-NP O
: : O O
71 CD B-NP O
in IN B-ADVP O
. . O O
-weight NN B-NP O
: : O O
173 CD B-NP O
lbs NNS I-NP O
. . O O
-General JJ B-NP O
: : O O
No DT B-NP O
acute JJ I-NP O
distress NN I-NP O
. . O O
-Skin NNP B-NP O
: : O O
No DT B-NP O
rashes NNS I-NP O
, , O O
anicteric JJ B-ADJP O
. . O O
-HEENT JJ B-NP O
: : O O
Unremarkable JJ O O
-Neck NN B-NP O
: : O O
Carotids NNP B-NP O
2+ CD I-NP O
without IN B-PP O
bruits NNS B-NP O
. . O O
JVP NN B-VP O
no DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
. . O O
-Chest NN B-NP O
: : O O
Clear NNP B-NP O
to TO B-PP O
auscultation NN B-NP O
and CC I-NP O
percussion NN I-NP O
. . O O
-Cardiac JJ B-NP O
: : O O
Left VBN B-VP O
ventricular JJ B-NP O
impulse NN I-NP O
discrete NN I-NP O
and CC O O
nondisplaced JJ B-NP O
. . O O
Regular JJ B-NP O
rate NN I-NP O
and CC I-NP O
rhythm NN I-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC I-NP O
S2 NNP I-NP O
, , O O
with IN B-PP O
no DT B-NP O
S3 NNP I-NP O
or CC I-NP O
S4 NNP I-NP O
. . O O
There EX B-NP O
were VBD B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
clicks VBZ B-VP O
or CC I-VP O
rubs VBZ I-VP O
. . O O
-Abdomen NNS B-NP O
: : O O
Normal JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
soft JJ B-NP O
and CC I-NP O
nontender JJ I-NP O
, , O O
with IN B-PP O
no DT B-NP O
hepatosplenomegaly NN I-NP O
or CC I-NP O
masses NNS I-NP O
appreciated VBN B-VP O
. . O O
-Extremities NNS B-NP O
: : O O
No DT B-NP O
cyanosis NN I-NP O
, , I-NP O
clubbing VBG I-NP O
or CC I-NP O
edema NN I-NP O
. . O O
2+ '' O O
femoral JJ B-NP O
pulses NNS I-NP O
without IN B-PP O
bruits NNS B-NP O
. . O O
2+ CD B-NP O
pedal NN I-NP O
pulses NNS I-NP O
. . O O
EKG NNP B-NP O
: : O O
NSR NNP B-NP O
68 CD I-NP O
w/ NN I-NP O
occas NN I-NP O
PVC. NNP I-NP O
PRWP NNP I-NP O
and CC I-NP O
NSSTTWA NNP I-NP O
. . O O
Selected NNP B-NP O
recent JJ I-NP O
labs NNS I-NP O
: : O O
Metabolic NNP B-NP O
Date NNP B-NP O
NA NNP I-NP O
K NNP I-NP O
CL VBZ B-VP O
CO2 NNP B-NP O
BUN NNP I-NP O
CRE NNP I-NP O
GLU NNP I-NP O
CA NNP I-NP O
PHOS NNP I-NP O
MG NNP I-NP O
01/12/49 CD B-NP B-DATE
139 CD I-NP O
3.8 CD I-NP O
103 CD I-NP O
26.0 CD I-NP O
17 CD I-NP O
1.2 CD I-NP O
151 CD I-NP O
1.6 CD O O
01/11/49 CD B-NP B-DATE
9.1 CD I-NP O
3.4 CD O O
Lipid/Thyroid NNP B-NP O
Date NNP B-NP O
CHOL NNP I-NP O
TRIG NNP I-NP O
HDL NNP I-NP O
LDL NNP I-NP O
01/11/49 CD B-NP B-DATE
139 CD I-NP O
131 CD I-NP O
36 CD I-NP O
77 CD O O
Hematology NNP B-NP O
Date NNP B-NP O
HCT NNP I-NP O
WBC NNP I-NP O
PLT . O O
01/12/49 CD B-NP B-DATE
40.0 CD I-NP O
7.9 CD I-NP O
185 CD O O
Urinalysis NN B-NP O
Date NNP B-NP O
UA-GLUC NNP I-NP O
UA-SPGR NNP I-NP O
UA-BLD NNP I-NP O
UA-PH NNP I-NP O
UA-PROT NNP I-NP O
UA-NIT . O O
01/10/49 CD B-NP B-DATE
NEGATIVE JJ I-NP O
1.010 CD I-NP O
1+ JJ I-NP O
5.0 CD I-NP O
1+ CD I-NP O
NEGATIVE JJ I-NP O
Immunology NNP B-NP O
Date NNP B-NP O
HGBA1C CC O O
01/11/49 CD B-NP B-DATE
6.60 CD I-NP O
other JJ O O
Date NNP B-NP O
MEAN-GLU NNP I-NP O
01/11/49 CD B-NP B-DATE
134 CD I-NP O
Assessment NNP B-NP O
and CC I-NP O
plan NN I-NP O
: : O O
Mr. NNP B-NP O
Eubanks NNS I-NP B-PATIENT
has VBZ B-VP O
CAD NNP B-NP O
and CC I-NP O
had VBD B-VP O
a DT B-NP O
recent JJ I-NP O
UAP NNP I-NP O
w/o NN I-NP O
MI NNP I-NP O
admission NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
moderate JJ B-NP O
multivessel NN I-NP O
CAD NN I-NP O
and CC O O
was VBD B-VP O
treated VBN I-VP O
w/ IN B-PP O
Cypher NNP B-NP O
stent NN I-NP O
x NN B-VP O
3 CD B-NP O
to TO B-PP O
the DT B-NP O
severe JJ I-NP O
stenoses NNS I-NP O
in IN B-PP O
his PRP$ B-NP O
mid JJ I-NP O
and CC I-NP O
distal JJ I-NP O
LAD. NNP I-NP O
His PRP$ B-NP O
followup JJ I-NP O
stress NN I-NP O
test NN I-NP O
was VBD B-VP O
negative JJ B-ADJP O
for IN B-PP O
ischemia NN B-NP O
and CC O O
he PRP B-NP O
has VBZ B-VP O
an DT B-NP O
appt NN I-NP O
at IN B-PP O
cardiac JJ B-NP O
rehab NN I-NP O
on IN B-PP O
3/29 CD B-NP B-DATE
. . O O
Problems NNS B-NP O
: : O O
Diabetes NNP B-NP O
mellitus NN I-NP O
(adult NN I-NP O
onset NN I-NP O
) -RRB- I-NP O
. . O O
Hyperlipidemia NNP B-NP O
. . O O
Pulmonary JJ B-NP O
nodule NN I-NP O
. . O O
Hypertension NNP B-NP O
. . O O
Coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
. . O O
Changes NNS B-NP O
to TO B-PP O
Medications NNS B-NP O
this DT B-NP O
visit NN I-NP O
lisinopril NN B-NP O
10 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd VBD B-VP O
QTY:30 CD B-NP O
Refills NNS I-NP O
:11 . O O
atenolol NN B-NP O
50mg CD I-NP O
po NN I-NP O
qd NN I-NP O
QTY:30 IN B-PP O
Refills NNP B-NP O
:11 CD I-NP O
Lipitor NNP B-NP O
80mg CD I-NP O
po NN I-NP O
qd JJ I-NP O
End NN I-NP O
: : O O
03/18/2149 CD B-NP B-DATE
DC NNP I-NP O
reason NN I-NP O
: : O O
Other JJ B-NP O
- : O O
Inactivated CC O O
Plavix NNP B-NP O
75mg CD I-NP O
po NN I-NP O
qd VBD B-VP O
QTY:30 CD B-NP O
Refills NNS I-NP O
:11 . O O
omeprazole NN B-NP O
20mg CD I-NP O
po NN I-NP O
qd VBD B-VP O
QTY:30 CD B-NP O
Refills NNS I-NP O
:11 . O O
colchicine NN B-NP O
0.6 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd VBD B-VP O
Start NNP B-NP O
: : O O
03/18/2149 CD O B-DATE
ASA NNP B-NP O
325 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd . O O
Indocin IN B-PP O
50 CD B-NP O
mg JJ I-NP O
po NN I-NP O
bid NN I-NP O
PRN NNP I-NP O
gout NN I-NP O
flares NNS I-NP O
Start NNP I-NP O
: : O O
03/18/2149 CD O B-DATE
simvastatin NN B-NP O
40mg CD I-NP O
po NN I-NP O
qpm NN I-NP O
QTY:30 IN B-PP O
Refills NNP B-NP O
:11 CD I-NP O
Start NNP I-NP O
: : O O
03/18/2149 CD O B-DATE
- : B-NP O
Mae NNP I-NP B-DOCTOR
S. NNP I-NP I-DOCTOR
Naylor NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
pager NN I-NP O
# # I-NP O
76228 CD O B-PHONE
Document NNP B-NP O
Status NNP I-NP O
: : O O
Preliminary JJ O O
